Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma

Published:2008-07 Issue:7 Volume:14 Page:840-846
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Wildes Tanya M.,Augustin Kristan M.,Sempek Diane,Zhang Qin Jean,Vij Ravi,Dipersio John F.,Devine Steven M.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant;Miller;J Clin Oncol,1996

2. High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working Party;Sweetenham;Bone Marrow Transplant,1994

3. Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution;Magagnoli;Am J Hematol,2003

4. High-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly versus younger lymphoma patients: a matched analysis;Magagnoli;Leuk Lymphoma,2003

5. Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report;Mazza;Bone Marrow Transplant,1999

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Impact of Comorbidity, Nutritional and Performance Status on Patients with Diffuse Large B Cell Lymphoma;Nigerian Journal of Clinical Practice;2023-10

2. Comparison of Inpatient Outcomes Between HIV Positive and Negative Hospitalizations for Autologous Stem Cell Transplant Treatment among Lymphoid Malignancies;Clinical Lymphoma Myeloma and Leukemia;2023-09

3. Quantitative evaluation of therapy options for relapsed/refractory diffuse large B-cell lymphoma: A model-based meta-analysis;Pharmacological Research;2023-01

4. Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population;European Journal of Cancer;2022-11

5. Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population;Cell Transplantation;2022-01